Showing posts with label approval. Show all posts
Showing posts with label approval. Show all posts
Monday, January 24, 2022

FDA Approves Apretude

›
  ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Lim...
Thursday, November 19, 2020

FDA Approves Zeposia (ozanimod) for Relapsing Forms of Multiple Sclerosis

›
Myers Squibb Company (NYSE: BMY)  announced that the U.S. Food and Drug Administration (FDA) approved  Zeposia  (ozanimod) 0.92 mg for the t...
Friday, November 13, 2020

FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease

›
The U.S. Food and Drug Administration today approved  Isturisa  (osilodrostat) oral tablets for adults with Cushing’s disease who either can...
Tuesday, December 24, 2019

Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline Depot (lanreotide)

›
  Ipsen Biopharmaceuticals, an affiliate of Ipsen , announced today that the United States Food and Drug Administration (FDA) has appr...
Wednesday, July 3, 2019

FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients

›
The U.S. Food and Drug Administration today approved Mavyret (telaprevir and pibrentasvir) tablets to treat all six genotypes of hepatit...
Tuesday, July 2, 2019

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

›
In continuation of my update on  dapagliflozin , and metformin hydrochloride   Dapagliflozin               Saxagliptin    ...
Saturday, April 27, 2019

FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism

›
  The U.S. Food and Drug Administration  approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certa...
Thursday, April 25, 2019

FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression

›
   In continuation of my update on  esketamine The U.S. Food and Drug Administration   approved   Spravato   (esketamine) nasal sp...
Tuesday, March 5, 2019

FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression

›
     The Janssen Pharmaceutical Companies of Johnson & Johnson  announced that the U.S. Food and Drug Administration (FDA) Psychop...
Tuesday, February 13, 2018

FDA grants approval for first drug to treat inherited breast cancer

›
In continuation of my update on olaparib The U.S. Food and Drug Administration  expanded the approved use of Lynparza (olaparib tabl...